Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Myeloid Leukemia Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 DC Regimen
1.2.3 AVD Regimen
1.2.4 VCD Regimen
1.3 Market by Application
1.3.1 Global Acute Myeloid Leukemia Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Myeloid Leukemia Treatment Market Perspective (2018-2033)
2.2 Acute Myeloid Leukemia Treatment Growth Trends by Region
2.2.1 Global Acute Myeloid Leukemia Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Acute Myeloid Leukemia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Acute Myeloid Leukemia Treatment Forecasted Market Size by Region (2024-2033)
2.3 Acute Myeloid Leukemia Treatment Market Dynamics
2.3.1 Acute Myeloid Leukemia Treatment Industry Trends
2.3.2 Acute Myeloid Leukemia Treatment Market Drivers
2.3.3 Acute Myeloid Leukemia Treatment Market Challenges
2.3.4 Acute Myeloid Leukemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Myeloid Leukemia Treatment Players by Revenue
3.1.1 Global Top Acute Myeloid Leukemia Treatment Players by Revenue (2018-2023)
3.1.2 Global Acute Myeloid Leukemia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Acute Myeloid Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Myeloid Leukemia Treatment Revenue
3.4 Global Acute Myeloid Leukemia Treatment Market Concentration Ratio
3.4.1 Global Acute Myeloid Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Treatment Revenue in 2022
3.5 Acute Myeloid Leukemia Treatment Key Players Head office and Area Served
3.6 Key Players Acute Myeloid Leukemia Treatment Product Solution and Service
3.7 Date of Enter into Acute Myeloid Leukemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Myeloid Leukemia Treatment Breakdown Data by Type
4.1 Global Acute Myeloid Leukemia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Type (2024-2033)
5 Acute Myeloid Leukemia Treatment Breakdown Data by Application
5.1 Global Acute Myeloid Leukemia Treatment Historic Market Size by Application (2018-2023)
5.2 Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Acute Myeloid Leukemia Treatment Market Size (2018-2033)
6.2 North America Acute Myeloid Leukemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Acute Myeloid Leukemia Treatment Market Size by Country (2018-2023)
6.4 North America Acute Myeloid Leukemia Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Myeloid Leukemia Treatment Market Size (2018-2033)
7.2 Europe Acute Myeloid Leukemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Acute Myeloid Leukemia Treatment Market Size by Country (2018-2023)
7.4 Europe Acute Myeloid Leukemia Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size (2018-2033)
8.2 Asia-Pacific Acute Myeloid Leukemia Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Myeloid Leukemia Treatment Market Size (2018-2033)
9.2 Latin America Acute Myeloid Leukemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Acute Myeloid Leukemia Treatment Market Size by Country (2018-2023)
9.4 Latin America Acute Myeloid Leukemia Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size (2018-2033)
10.2 Middle East & Africa Acute Myeloid Leukemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ambit Biosciences Corporation
11.1.1 Ambit Biosciences Corporation Company Detail
11.1.2 Ambit Biosciences Corporation Business Overview
11.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Introduction
11.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023)
11.1.5 Ambit Biosciences Corporation Recent Development
11.2 Celgene Corporation
11.2.1 Celgene Corporation Company Detail
11.2.2 Celgene Corporation Business Overview
11.2.3 Celgene Corporation Acute Myeloid Leukemia Treatment Introduction
11.2.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023)
11.2.5 Celgene Corporation Recent Development
11.3 Cephalon
11.3.1 Cephalon Company Detail
11.3.2 Cephalon Business Overview
11.3.3 Cephalon Acute Myeloid Leukemia Treatment Introduction
11.3.4 Cephalon Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023)
11.3.5 Cephalon Recent Development
11.4 Clavis Pharma
11.4.1 Clavis Pharma Company Detail
11.4.2 Clavis Pharma Business Overview
11.4.3 Clavis Pharma Acute Myeloid Leukemia Treatment Introduction
11.4.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023)
11.4.5 Clavis Pharma Recent Development
11.5 Eisai
11.5.1 Eisai Company Detail
11.5.2 Eisai Business Overview
11.5.3 Eisai Acute Myeloid Leukemia Treatment Introduction
11.5.4 Eisai Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023)
11.5.5 Eisai Recent Development
11.6 Genzyme Corporation
11.6.1 Genzyme Corporation Company Detail
11.6.2 Genzyme Corporation Business Overview
11.6.3 Genzyme Corporation Acute Myeloid Leukemia Treatment Introduction
11.6.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023)
11.6.5 Genzyme Corporation Recent Development
11.7 Sunesis Pharmaceuticals
11.7.1 Sunesis Pharmaceuticals Company Detail
11.7.2 Sunesis Pharmaceuticals Business Overview
11.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Introduction
11.7.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023)
11.7.5 Sunesis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acute Myeloid Leukemia Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of DC Regimen
Table 3. Key Players of AVD Regimen
Table 4. Key Players of VCD Regimen
Table 5. Global Acute Myeloid Leukemia Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Acute Myeloid Leukemia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Acute Myeloid Leukemia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Acute Myeloid Leukemia Treatment Market Share by Region (2018-2023)
Table 9. Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Acute Myeloid Leukemia Treatment Market Share by Region (2024-2033)
Table 11. Acute Myeloid Leukemia Treatment Market Trends
Table 12. Acute Myeloid Leukemia Treatment Market Drivers
Table 13. Acute Myeloid Leukemia Treatment Market Challenges
Table 14. Acute Myeloid Leukemia Treatment Market Restraints
Table 15. Global Acute Myeloid Leukemia Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Acute Myeloid Leukemia Treatment Market Share by Players (2018-2023)
Table 17. Global Top Acute Myeloid Leukemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Treatment as of 2022)
Table 18. Ranking of Global Top Acute Myeloid Leukemia Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Myeloid Leukemia Treatment Product Solution and Service
Table 22. Date of Enter into Acute Myeloid Leukemia Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Myeloid Leukemia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global Acute Myeloid Leukemia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Application (2024-2033)
Table 32. North America Acute Myeloid Leukemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Acute Myeloid Leukemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Acute Myeloid Leukemia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Acute Myeloid Leukemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Acute Myeloid Leukemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Acute Myeloid Leukemia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Acute Myeloid Leukemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Acute Myeloid Leukemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Acute Myeloid Leukemia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. Ambit Biosciences Corporation Company Detail
Table 48. Ambit Biosciences Corporation Business Overview
Table 49. Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Product
Table 50. Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023) & (US$ Million)
Table 51. Ambit Biosciences Corporation Recent Development
Table 52. Celgene Corporation Company Detail
Table 53. Celgene Corporation Business Overview
Table 54. Celgene Corporation Acute Myeloid Leukemia Treatment Product
Table 55. Celgene Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023) & (US$ Million)
Table 56. Celgene Corporation Recent Development
Table 57. Cephalon Company Detail
Table 58. Cephalon Business Overview
Table 59. Cephalon Acute Myeloid Leukemia Treatment Product
Table 60. Cephalon Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023) & (US$ Million)
Table 61. Cephalon Recent Development
Table 62. Clavis Pharma Company Detail
Table 63. Clavis Pharma Business Overview
Table 64. Clavis Pharma Acute Myeloid Leukemia Treatment Product
Table 65. Clavis Pharma Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023) & (US$ Million)
Table 66. Clavis Pharma Recent Development
Table 67. Eisai Company Detail
Table 68. Eisai Business Overview
Table 69. Eisai Acute Myeloid Leukemia Treatment Product
Table 70. Eisai Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023) & (US$ Million)
Table 71. Eisai Recent Development
Table 72. Genzyme Corporation Company Detail
Table 73. Genzyme Corporation Business Overview
Table 74. Genzyme Corporation Acute Myeloid Leukemia Treatment Product
Table 75. Genzyme Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023) & (US$ Million)
Table 76. Genzyme Corporation Recent Development
Table 77. Sunesis Pharmaceuticals Company Detail
Table 78. Sunesis Pharmaceuticals Business Overview
Table 79. Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Product
Table 80. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Treatment Business (2018-2023) & (US$ Million)
Table 81. Sunesis Pharmaceuticals Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Acute Myeloid Leukemia Treatment Market Share by Type: 2022 VS 2033
Figure 3. DC Regimen Features
Figure 4. AVD Regimen Features
Figure 5. VCD Regimen Features
Figure 6. Global Acute Myeloid Leukemia Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Acute Myeloid Leukemia Treatment Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Acute Myeloid Leukemia Treatment Report Years Considered
Figure 12. Global Acute Myeloid Leukemia Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Acute Myeloid Leukemia Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Acute Myeloid Leukemia Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Acute Myeloid Leukemia Treatment Market Share by Players in 2022
Figure 16. Global Top Acute Myeloid Leukemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Treatment Revenue in 2022
Figure 18. North America Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Acute Myeloid Leukemia Treatment Market Share by Country (2018-2033)
Figure 20. United States Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Acute Myeloid Leukemia Treatment Market Share by Country (2018-2033)
Figure 24. Germany Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Acute Myeloid Leukemia Treatment Market Share by Region (2018-2033)
Figure 32. China Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Acute Myeloid Leukemia Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Acute Myeloid Leukemia Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Acute Myeloid Leukemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Ambit Biosciences Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2018-2023)
Figure 47. Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2018-2023)
Figure 48. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2018-2023)
Figure 49. Clavis Pharma Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2018-2023)
Figure 50. Eisai Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2018-2023)
Figure 51. Genzyme Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2018-2023)
Figure 52. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed